$INTZ
INTRUSION INC Stock $intz

$intz Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000168316823003395 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$1.468M	$1.309M	$1.835M
YoY Change	-28.67%	-28.66%	-0.81%
Cost Of Revenue	$330.0K	$313.0K	$654.0K
YoY Change	-50.52%	-52.14%	3.81%
Gross Profit	$1.138M	$996.0K	$1.181M
YoY Change	-18.19%	-15.66%	-3.98%
Gross Profit Margin	77.52%	76.09%	64.36%
Selling, General & Admin	$2.608M	$3.244M	$3.515M
YoY Change	-32.54%	-7.71%	-3.96%
% of Gross Profit	229.17%	325.7%	297.63%
Research & Development	$1.451M	$1.796M	$1.650M
YoY Change	-2.36%	8.85%	12.24%
% of Gross Profit	127.5%	180.32%	139.71%
Depreciation & Amortization	$401.0K	$397.0K	$312.0K
YoY Change	31.91%	27.24%	290.0%
% of Gross Profit	35.24%	39.86%	26.42%
Operating Expenses	$4.059M	$5.040M	$5.165M
YoY Change	-24.16%	-2.42%	0.68%
Operating Profit	-$2.921M	-$4.044M	-$3.984M
YoY Change	-26.26%	1.51%	2.15%
Interest Expense	$208.0K	$731.0K	-$70.00K
YoY Change	-60.38%	-1144.29%
% of Operating Profit
Other Income/Expense, Net	$0.00	$41.00K
YoY Change
Pretax Income	-$3.129M	-$4.734M	-$4.054M
YoY Change	-23.03%	16.77%	3.95%
Income Tax
% Of Pretax Income
Net Earnings	-$3.129M	-$4.734M	-$4.054M
YoY Change	-23.03%	16.77%	3.95%
Net Earnings / Revenue	-213.15%	-361.65%	-220.93%
Basic Earnings Per Share	-$0.15	-$0.22	-$0.21
Diluted Earnings Per Share	-$0.15	-$0.22	-$212.1K
COMMON SHARES
Basic Shares Outstanding	21.33M shares	21.25M shares	19.11M shares
Diluted Shares Outstanding	21.38M shares	21.07M shares	19.11M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$300.0K	$411.0K	$6.079M
YoY Change	-95.73%	-93.24%	-53.6%
Cash & Equivalents	$300.0K	$411.0K	$6.079M
Short-Term Investments
Other Short-Term Assets	$427.0K	$372.0K	$648.0K
YoY Change	-45.54%	-42.59%	-7.43%
Inventory
Prepaid Expenses
Receivables	$211.0K	$470.0K	$1.174M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$938.0K	$1.253M	$7.901M
YoY Change	-89.68%	-84.14%	-47.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.529M	$2.505M	$3.350M
YoY Change	101.84%	-25.22%	109.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$147.0K	$141.0K	$165.0K
YoY Change	-9.82%	-14.55%	-17.5%
Total Long-Term Assets	$3.739M	$3.955M	$3.515M
YoY Change	8.35%	12.52%	106.76%
TOTAL ASSETS
Total Short-Term Assets	$938.0K	$1.253M	$7.901M
Total Long-Term Assets	$3.739M	$3.955M	$3.515M
Total Assets	$4.677M	$5.208M	$11.42M
YoY Change	-62.71%	-54.38%	-32.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.798M	$1.511M	$807.0K
YoY Change	-75.43%	87.24%	-10.33%
Accrued Expenses	$212.0K	$524.0K	$1.931M
YoY Change	-75.69%	-72.86%	48.54%
Deferred Revenue	$1.121M	$166.0K
YoY Change	-14.69%
Short-Term Debt	$10.89M	$10.74M	$0.00
YoY Change
Long-Term Debt Due	$618.0K	$658.0K	$3.506M
YoY Change	-4.92%	-81.23%	776.5%
Total Short-Term Liabilities	$14.83M	$13.84M	$6.581M
YoY Change	41.7%	110.24%	143.74%
LONG-TERM LIABILITIES
Long-Term Debt	$4.000K	$5.000K	$2.446M
YoY Change	-99.89%	-99.8%	1123.0%
Other Long-Term Liabilities	$167.0K	$199.0K	$1.087M
YoY Change	-55.11%	-81.69%	-36.06%
Total Long-Term Liabilities	$171.0K	$204.0K	$3.533M
YoY Change	-95.65%	-94.23%	85.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.83M	$13.84M	$6.581M
Total Long-Term Liabilities	$171.0K	$204.0K	$3.533M
Total Liabilities	$15.00M	$14.04M	$10.11M
YoY Change	4.18%	38.82%	115.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$104.2M	-$101.1M
YoY Change	18.11%
Common Stock	$224.0K	$212.0K
YoY Change	13.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$10.32M	-$8.832M
YoY Change
Total Liabilities & Shareholders Equity	$4.677M	$5.208M	$11.42M
YoY Change	-62.71%	-54.38%	-32.05%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$3.129M	-$4.734M	-$4.054M
YoY Change	-23.03%	16.77%	3.95%
Depreciation, Depletion And Amortization	$401.0K	$397.0K	$312.0K
YoY Change	31.91%	27.24%	290.0%
Cash From Operating Activities	-$963.0K	-$2.312M	-$3.471M
YoY Change	-73.65%	-33.39%	-3.31%
INVESTING ACTIVITIES
Capital Expenditures	$416.0K	$4.000K	-$160.0K
YoY Change	-231.65%	-102.5%	-20.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$416.0K	-$301.0K	-$160.0K
YoY Change	31.65%	88.13%	-20.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.268M	$9.000K	5.610M
YoY Change	-74.17%	-99.84%	3640.0%
NET CHANGE
Cash From Operating Activities	-963.0K	-$2.312M	-3.471M
Cash From Investing Activities	-416.0K	-$301.0K	-160.0K
Cash From Financing Activities	1.268M	$9.000K	5.610M
Net Change In Cash	-111.0K	-$2.604M	1.979M
YoY Change	-111.82%	-231.58%	-154.37%
FREE CASH FLOW
Cash From Operating Activities	-$963.0K	-$2.312M	-$3.471M
Capital Expenditures	$416.0K	$4.000K	-$160.0K
Free Cash Flow	-$1.379M	-$2.316M	-$3.311M
YoY Change	-58.69%	-30.05%	-2.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000736012
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	0-20191
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	INTRUSION INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-1911917
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	101 East Park Blvd
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1200
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Plano
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75074
CY2023Q1	dei	City Area Code CityAreaCode	(972)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	234-6400
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	INTZ
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21331604	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	411000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3015000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	470000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	530000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	372000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1877000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1253000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	5422000	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	2890000	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	2865000	usd
CY2023Q1	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	1934000	usd
CY2022Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	1380000	usd
CY2023Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	43000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	43000	usd
CY2023Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	78000	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	78000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4945000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4366000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2440000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2208000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2505000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2158000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	882000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1048000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	427000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	504000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	141000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	143000	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	3955000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3853000	usd
CY2023Q1	us-gaap	Assets Assets	5208000	usd
CY2022Q4	us-gaap	Assets Assets	9275000	usd
CY2023Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1511000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1273000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	524000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	446000	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	658000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	667000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	240000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	294000	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	10737000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	10114000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	166000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	455000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	13836000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13249000	usd
CY2023Q1	intz	Finance Lease Liabilities Noncurrent Portion FinanceLeaseLiabilitiesNoncurrentPortion	5000	usd
CY2022Q4	intz	Finance Lease Liabilities Noncurrent Portion FinanceLeaseLiabilitiesNoncurrentPortion	10000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	199000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	231000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	204000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	241000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21258000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21198000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21248000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21188000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	212000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	212000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	10000	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	10000	shares
CY2023Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	362000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	362000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	92421000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	92304000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-101060000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-96326000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-43000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-43000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-8832000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4215000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5208000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9275000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1309000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1835000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	313000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	903000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	996000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	932000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1738000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1206000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1796000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1650000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1506000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2060000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4044000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3984000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	731000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	71000	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	41000	usd
CY2022Q1	us-gaap	Interest Income Other InterestIncomeOther	1000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4734000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4054000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21065000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19113000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21065000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19113000	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4215000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	94000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	21000	usd
CY2023Q1	intz	Tax Withholdings Related To Stockbased Compensation Awards TaxWithholdingsRelatedToStockbasedCompensationAwards	5000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4734000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-8832000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3919000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	949000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	427000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	61000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4054000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1302000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4734000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4054000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	397000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	312000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	94000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	427000	usd
CY2023Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	77000	usd
CY2022Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	75000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	327000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	37000	usd
CY2023Q1	intz	Noncash Interest And Interest Accretion Up To Redemption Common Stock Settlement Amount NoncashInterestAndInterestAccretionUpToRedemptionCommonStockSettlementAmount	296000	usd
CY2022Q1	intz	Noncash Interest And Interest Accretion Up To Redemption Common Stock Settlement Amount NoncashInterestAndInterestAccretionUpToRedemptionCommonStockSettlementAmount	23000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-60000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	140000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1507000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	293000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	39000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	427000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-86000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-62000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-289000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-223000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2312000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3471000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	160000	usd
CY2023Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	297000	usd
CY2022Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	-0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-301000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-160000	usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	5000000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	-0	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	394000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	21000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	949000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	62000	usd
CY2023Q1	intz	Tax Withholdings Related To Stockbased Compensations Awards TaxWithholdingsRelatedToStockbasedCompensationsAwards	5000	usd
CY2022Q1	intz	Tax Withholdings Related To Stockbased Compensations Awards TaxWithholdingsRelatedToStockbasedCompensationsAwards	-0	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	14000	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	7000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5610000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2604000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1979000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3015000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4100000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	411000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6079000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	109000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1000	usd
CY2023Q1	intz	Capitalized Asset And Capitalized Software Included In Accounts Payable CapitalizedAssetAndCapitalizedSoftwareIncludedInAccountsPayable	277000	usd
CY2022Q1	intz	Capitalized Asset And Capitalized Software Included In Accounts Payable CapitalizedAssetAndCapitalizedSoftwareIncludedInAccountsPayable	0	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	400000	usd
CY2023Q1	intz	Working Capital WorkingCapital	12600000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	86000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	75000	usd
CY2023Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	14000	usd
CY2022Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	7000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	166000	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	166000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	77000	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	95000	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	6000	usd
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	7000	usd
CY2023Q1	intz	Lessee Operating And Finance Lease Liability Payments Due In Rolling Year Two LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearTwo	878000	usd
CY2023Q1	intz	Lessee Operating And Finance Lease Liability Payments Due In Rolling Year Three LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearThree	131000	usd
CY2023Q1	intz	Lessee Operating And Finance Lease Liability Payments Due In Rolling Year Four LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearFour	118000	usd
CY2023Q1	intz	Lessee Operating And Finance Lease Liability Payments Due In Rolling Year Five LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearFive	0	usd
CY2023Q1	intz	Lessee Operating And Finance Lease Liability Payments Due LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue	1127000	usd
CY2023Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	600000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	300000	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	37000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	300000	usd
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	23000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	668000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.22
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	561000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.24
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	67000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.48
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	54000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	9.54
CY2023Q1	intz	Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod	0	shares
CY2023Q1	intz	Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1108000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.28
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	337000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	10.77
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.08
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.34
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0369	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0088	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.154	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.330	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y7M6D
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	500000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	500000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	455000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	560000	usd
CY2023Q1	intz	Contract Liabilities Additions ContractLiabilitiesAdditions	255000	usd
CY2022	intz	Contract Liabilities Additions ContractLiabilitiesAdditions	1877000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-544000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-1982000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	166000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	455000	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2057000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	925000	shares

Files In Submission

Name	View Source	Status
intz-20230331_pre.xml	Edgar Link	unprocessable
0001683168-23-003395-index-headers.html	Edgar Link	pending
0001683168-23-003395-index.html	Edgar Link	pending
0001683168-23-003395.txt	Edgar Link	pending
0001683168-23-003395-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
intrusion_ex3101.htm	Edgar Link	pending
intrusion_ex3102.htm	Edgar Link	pending
intrusion_ex3200.htm	Edgar Link	pending
intrusion_i10q-33123.htm	Edgar Link	pending
intz-20230331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
intz-20230331_cal.xml	Edgar Link	unprocessable
intz-20230331_def.xml	Edgar Link	unprocessable
intz-20230331_lab.xml	Edgar Link	unprocessable
intrusion_i10q-33123_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INTZ
INTRUSION INC Stock $intz

2023 Q2 Form 10-Q Financial Statement

#000168316823003395 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INTZ INTRUSION INC Stock $intz

2023 Q2 Form 10-Q Financial Statement

#000168316823003395 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INTZ
INTRUSION INC Stock $intz